AT HIS NOMINATION hearing in January 2025, Robert F. Kennedy Jr. announced he’d “do everything in my power to put the health ...
GeneDx, a fast-growing biotech doing exome and genomic testing, has seen big returns on Wall Street as appetite for its tests grow in the clinic.